Heptares Therapeutics
Sanesh Mistry has worked as a Senior Scientist I at Sosei Heptares since January 2023. Before that, they were a Research And Development Scientist at Veranova from June 2022 to January 2023. Sanesh also worked as a Senior Scientist (Process Chemistry) at AstraZeneca from September 2020 to June 2022. Prior to that, they had a chemistry placement at AstraZeneca from September 2018 to November 2018.
Sanesh Mistry pursued their higher education from 2016 to 2020 at the University of Cambridge. During this time, they obtained a Doctor of Philosophy (PhD) degree in Organic Chemistry.
This person is not in the org chart
Heptares Therapeutics
Heptares Therapeutics is a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets.The Company has developed a unique, transformational and proprietary technology for making purified, stabilised and functional GPCRs (known as StaRs, StabilisedReceptors), overcoming a major limiting factor to the development of new drugs targeting this group.